Letters

Illogical Pathways Eugene Garfield in his editorial on “Recognizing the Role of Chance” (May 2, page 10) touches upon a point of more realistically reporting the role of serendipity in the research process. This is only one aspect of the publication of scientific papers that needs more discussion and consensus among scientists. I have long felt that the gloss of a hypothetico-deductive style in a research paper may overstate the degree of support for an author’s claim, if

Written byDonald Zilversmit
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Eugene Garfield in his editorial on “Recognizing the Role of Chance” (May 2, page 10) touches upon a point of more realistically reporting the role of serendipity in the research process. This is only one aspect of the publication of scientific papers that needs more discussion and consensus among scientists.

I have long felt that the gloss of a hypothetico-deductive style in a research paper may overstate the degree of support for an author’s claim, if the data were actually obtained by a combination of chance events and inconclusive experiments.

It is often said that the pressure on scientists to publish papers arises from the need to obtain research grants and to advance their careers. I believe that, in addition, there are more mundane pressures to publish a paper of partly finished research. Such a paper can result when a student’s M.S. or Ph.D. thesis has been judged acceptable, when ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies